{"entity":{"type":"insider","cik":"0001851034","url":"/insider/0001851034","json_url":"/insider/0001851034.json","name":"Finley John David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":13,"first":"2021-08-30","last":"2026-07-08","span_basis":"filed_date"},"name_variants":[{"name":"Finley John David","source":"filing","n_filings":13,"first_seen":"2021-08-30","last_seen":"2026-07-08"}],"transactions":[{"id":6093351,"accession":"0001493152-26-032559","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-26-032559","line_url":"/filing/0001493152-26-032559#line-3","is_derivative":false,"issuer_cik":"0001357459","issuer_name":"PALISADE BIO, INC.","issuer_ticker":"PALI","issuer_name_source":null,"issuer_url":"/issuer/0001357459","owner_cik":"0001851034","owner_name":"Finley John David","owner_display_name":"Finley John David","owner_url":"/insider/0001851034","role":"Director, Officer (CEO, CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":146798.0,"shares_display":"146,798","price_per_share":2.0664,"price_display":"2.07","price_state":"stated","total_value":303343.3872,"total_display":"303,343.39","total_whole":"303,343","shares_owned_after":217555.0,"shares_owned_after_display":"217,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-07","filed_date":"2026-07-08","scope":"insider"},{"id":6093094,"accession":"0001493152-26-006831","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-26-006831","line_url":"/filing/0001493152-26-006831#line-2","is_derivative":false,"issuer_cik":"0001357459","issuer_name":"PALISADE BIO, INC.","issuer_ticker":"PALI","issuer_name_source":null,"issuer_url":"/issuer/0001357459","owner_cik":"0001851034","owner_name":"Finley John David","owner_display_name":"Finley John David","owner_url":"/insider/0001851034","role":"Director, Officer (CEO, CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3896.0,"shares_display":"3,896","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":6818.0,"total_display":"6,818.00","total_whole":"6,818","shares_owned_after":27353.0,"shares_owned_after_display":"27,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-13","scope":"insider"},{"id":2159502,"accession":"0001493152-24-021431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-021431","line_url":"/filing/0001493152-24-021431#line-1","is_derivative":false,"issuer_cik":"0001357459","issuer_name":"PALISADE BIO, INC.","issuer_ticker":"PALI","issuer_name_source":null,"issuer_url":"/issuer/0001357459","owner_cik":"0001851034","owner_name":"Finley John David","owner_display_name":"Finley John David","owner_url":"/insider/0001851034","role":"Director, Officer (CEO, CFO, Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, CFO, Director","security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.81,"price_display":"4.81","price_state":"stated","total_value":4810.0,"total_display":"4,810.00","total_whole":"4,810","shares_owned_after":8437.0,"shares_owned_after_display":"8,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-24","filed_date":"2024-05-28","scope":"insider"},{"id":3081318,"accession":"0001493152-24-005207","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-005207","line_url":"/filing/0001493152-24-005207#line-1","is_derivative":false,"issuer_cik":"0001357459","issuer_name":"PALISADE BIO, INC.","issuer_ticker":"PALI","issuer_name_source":null,"issuer_url":"/issuer/0001357459","owner_cik":"0001851034","owner_name":"Finley John David","owner_display_name":"Finley John David","owner_url":"/insider/0001851034","role":"Director, Officer (CEO, CFO, Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, CFO, Director","security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.4692,"price_display":"0.47","price_state":"stated","total_value":4692.0,"total_display":"4,692.00","total_whole":"4,692","shares_owned_after":84649.0,"shares_owned_after_display":"84,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-07","scope":"insider"},{"id":2819602,"accession":"0001493152-24-004566","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-004566","line_url":"/filing/0001493152-24-004566#line-1","is_derivative":false,"issuer_cik":"0001357459","issuer_name":"PALISADE BIO, INC.","issuer_ticker":"PALI","issuer_name_source":null,"issuer_url":"/issuer/0001357459","owner_cik":"0001851034","owner_name":"Finley John David","owner_display_name":"Finley John David","owner_url":"/insider/0001851034","role":"Director, Officer (CEO, CFO, Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, CFO, Director","security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.559,"price_display":"0.56","price_state":"stated","total_value":5590.0,"total_display":"5,590.00","total_whole":"5,590","shares_owned_after":74649.0,"shares_owned_after_display":"74,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-01","scope":"insider"},{"id":8556502,"accession":"0001493152-23-034754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-034754","line_url":"/filing/0001493152-23-034754#line-1","is_derivative":false,"issuer_cik":"0001357459","issuer_name":"PALISADE BIO, INC.","issuer_ticker":"PALI","issuer_name_source":null,"issuer_url":"/issuer/0001357459","owner_cik":"0001851034","owner_name":"Finley John David","owner_display_name":"Finley John David","owner_url":"/insider/0001851034","role":"Director, Officer (CEO, CFO, Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, CFO, Director","security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.5392,"price_display":"0.54","price_state":"stated","total_value":8088.0,"total_display":"8,088.00","total_whole":"8,088","shares_owned_after":43394.0,"shares_owned_after_display":"43,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"},{"id":7903401,"accession":"0001493152-23-032655","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-032655","line_url":"/filing/0001493152-23-032655#line-1","is_derivative":false,"issuer_cik":"0001357459","issuer_name":"PALISADE BIO, INC.","issuer_ticker":"PALI","issuer_name_source":null,"issuer_url":"/issuer/0001357459","owner_cik":"0001851034","owner_name":"Finley John David","owner_display_name":"Finley John David","owner_url":"/insider/0001851034","role":"Director, Officer (CEO, CFO, Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, CFO, Director","security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.655,"price_display":"0.66","price_state":"stated","total_value":9825.0,"total_display":"9,825.00","total_whole":"9,825","shares_owned_after":28394.0,"shares_owned_after_display":"28,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-13","filed_date":"2023-09-14","scope":"insider"},{"id":6246407,"accession":"0001493152-22-025023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-025023","line_url":"/filing/0001493152-22-025023#line-1","is_derivative":false,"issuer_cik":"0001357459","issuer_name":"PALISADE BIO, INC.","issuer_ticker":"PALI","issuer_name_source":null,"issuer_url":"/issuer/0001357459","owner_cik":"0001851034","owner_name":"Finley John David","owner_display_name":"Finley John David","owner_url":"/insider/0001851034","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19481.242,"shares_display":"19,481.24","price_per_share":0.1437,"price_display":"0.14","price_state":"stated","total_value":2799.4544754,"total_display":"2,799.45","total_whole":"2,799","shares_owned_after":148727.242,"shares_owned_after_display":"148,727.24","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-02","scope":"insider"},{"id":6726212,"accession":"0001493152-22-024082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-024082","line_url":"/filing/0001493152-22-024082#line-1","is_derivative":false,"issuer_cik":"0001357459","issuer_name":"PALISADE BIO, INC.","issuer_ticker":"PALI","issuer_name_source":null,"issuer_url":"/issuer/0001357459","owner_cik":"0001851034","owner_name":"Finley John David","owner_display_name":"Finley John David","owner_url":"/insider/0001851034","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7350.0,"shares_display":"7,350","price_per_share":0.16,"price_display":"0.16","price_state":"stated","total_value":1176.0,"total_display":"1,176.00","total_whole":"1,176","shares_owned_after":129246.0,"shares_owned_after_display":"129,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-23","filed_date":"2022-08-25","scope":"insider"},{"id":6450955,"accession":"0001493152-22-023510","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-023510","line_url":"/filing/0001493152-22-023510#line-1","is_derivative":false,"issuer_cik":"0001357459","issuer_name":"PALISADE BIO, INC.","issuer_ticker":"PALI","issuer_name_source":null,"issuer_url":"/issuer/0001357459","owner_cik":"0001851034","owner_name":"Finley John David","owner_display_name":"Finley John David","owner_url":"/insider/0001851034","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":121896.0,"shares_owned_after_display":"121,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-18","scope":"insider"},{"id":6273020,"accession":"0001209191-22-021051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-021051","line_url":"/filing/0001209191-22-021051#line-1","is_derivative":false,"issuer_cik":"0001357459","issuer_name":"PALISADE BIO, INC.","issuer_ticker":"PALI","issuer_name_source":null,"issuer_url":"/issuer/0001357459","owner_cik":"0001851034","owner_name":"Finley John David","owner_display_name":"Finley John David","owner_url":"/insider/0001851034","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":1.0899,"price_display":"1.09","price_state":"stated","total_value":8174.25,"total_display":"8,174.25","total_whole":"8,174","shares_owned_after":21896.0,"shares_owned_after_display":"21,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-24","filed_date":"2022-03-25","scope":"insider"},{"id":4793398,"accession":"0001209191-21-057319","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057319","line_url":"/filing/0001209191-21-057319#line-1","is_derivative":false,"issuer_cik":"0001357459","issuer_name":"PALISADE BIO, INC.","issuer_ticker":"PALI","issuer_name_source":null,"issuer_url":"/issuer/0001357459","owner_cik":"0001851034","owner_name":"Finley John David","owner_display_name":"Finley John David","owner_url":"/insider/0001851034","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.44,"price_display":"2.44","price_state":"stated","total_value":4880.0,"total_display":"4,880.00","total_whole":"4,880","shares_owned_after":14396.0,"shares_owned_after_display":"14,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-21","filed_date":"2021-09-22","scope":"insider"},{"id":4573509,"accession":"0001209191-21-053803","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-053803","line_url":"/filing/0001209191-21-053803","is_derivative":false,"issuer_cik":"0001357459","issuer_name":"PALISADE BIO, INC.","issuer_ticker":"PALI","issuer_name_source":null,"issuer_url":"/issuer/0001357459","owner_cik":"0001851034","owner_name":"Finley John David","owner_display_name":"Finley John David","owner_url":"/insider/0001851034","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.6468,"price_display":"2.65","price_state":"stated","total_value":26468.0,"total_display":"26,468.00","total_whole":"26,468","shares_owned_after":12396.0,"shares_owned_after_display":"12,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-27","filed_date":"2021-08-30","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001357459","name":"PALISADE BIO, INC.","url":"/issuer/0001357459","role":"Director, Officer (CEO, CFO)","n_filings":13,"first_seen":"2021-08-30","last_seen":"2026-07-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001851034","retrieved_at":"2026-08-23T17:45:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}